Drugs / lerisetron
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00004219 | — | testicular germ cell tumor | Simbec Research | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lerisetron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004219 ↗ |
| Modality | Small molecule | — CHEMBL56900 ↗ |
| Route | Oral | “Arm I: Patients receive oral lerisetron with an oral placebo once daily for 14 days.” NCT00004219 ↗ |